Allscripts is buying ZappRx, a prescription drug start-up [CNBC]
Veradigm Inc. (MDRX)
Last veradigm inc. earnings: 3/2 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.allscripts.com
Company Research
Source: CNBC
Allscripts is buying ZappRx, a prescription drug start-up Medical software company Allscripts ZappRx raised more than $40 million from investors ranging from GV, Alphabet In a statement, Allscripts said "Allscripts is excited to add ZappRx's platform to our growing portfolio. The specialty-prescribing space is a key focus area for Veradigm, our payer and life sciences business unit. While we cannot share the details of our agreement publicly, the addition of ZappRx's team and technology will augment our solution offerings and provide great value to our clients." The buy-up of ZappRx follows Amazon's acquisition of PillPack Allscripts' core business is selling electronic medical record software to hospitals and other health providers, and it acquired PracticeFusion, another electronic medical records company, in January ZappRx was founded in 2012 in Boston, Mass. Its CEO Zoe Barry previously worked on Wall Street, and started the company after her brother was diagnosed with severe epi
Show less
Read more
Impact Snapshot
Event Time:
MDRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MDRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MDRX alerts
High impacting Veradigm Inc. news events
Weekly update
A roundup of the hottest topics
MDRX
News
- Veradigm Inc. (NASDAQ: MDRX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Laurie McGraw Joins Transcarent as Executive Vice President [Yahoo! Finance]Yahoo! Finance
- Veradigm Inc. (NASDAQ: MDRX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Veradigm Network Solution Practice Fusion EHR Receives Top Ambulatory RankingsBusiness Wire
- Veradigm Inc. (NASDAQ: MDRX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
MDRX
Sec Filings
- 4/10/24 - Form 8-K
- 4/5/24 - Form SC
- 4/3/24 - Form 4
- MDRX's page on the SEC website